Proposed Sections
Before an agency may permanently adopt a new or amended section, or repeal an
existing section, a proposal detailing the action must be published in the Texas
Register at least 30 days before any action may be taken. The 30-day time period
gives interested persons an opportunity to review and make oral or written
comments on the section. Also, in the case of substantive sections, a public
hearing must be granted if requested by at least 25 persons, a governmental
subdivision or agency, or an association having at least 25 members.
Symbology in proposed amendments. New language added to an existing section is
indicated by the use of bold text. [Brackets] indicate deletion of existing
material within a section.
TITLE 22. EXAMINING BOARDS
Part XV. Texas State Board of Pharmacy
Chapter 291. Pharmacies
All Classes of Pharmacy
22 TAC sec.sec.291.5, 291.7, 291.12, 291.15-291.17
The Texas State Board of Pharmacy proposes amendments to ssec.291.5, 291. 7,
291.12, and 291.15-291.17, concerning Closed Pharmacies, Change of Pharmacist
Employment, Fire or Other Disaster, Notification of Theft or Loss of a
Controlled Substance, Definitions, and Controlled Substance Inventory
Requirements.
These amendments if adopted will require pharmacies to: (1) inventory
butorphanol (Stadolz), nalbuphine (Nubain) and carisoprodol (Soma) annually and
on change of pharmacist-in-charge; and report a theft or significant loss of
dangerous drugs.
Fred S. Brinkley, Jr., R.Ph., M.B.A., executive director/secretary, has
determined that for the first five-year period the sections are in effect there
will be no fiscal implications as a result of enforcing or administering the
sections.
Mr. Brinkley also has determined that for each year of the first five years the
sections are in effect the public benefit anticipated as a result of enforcing
the sections as proposed will be the protection of the health of the citizens of
the State of Texas through better control of these drugs. There will be no
effect on small businesses. There is no anticipated economic cost to persons who
are required to comply with the section as proposed.
Comments may be submitted to Fred S. Brinkly, Jr., R.Ph., M.B.A., Texas State
Board of Pharmacy, 8505 Cross Park Drive, Suite 110 Austin, Texas 78754-4533.
The amendments are proposed under the Texas Pharmacy Act (Texas Civil Statutes,
Article 4542a-1) sec.16(a), which provides the Texas State Board of Pharmacy the
authority to adopt rules for the proper administration and enforcement of the
Act; and sec.17(b), which provided the Board with the authority to specify the
minimum standards for maintenance of prescription drug records in a pharmacy.
sec.291.5. Closed Pharmacies.
The pharmacist-in-charge of a pharmacy that
ceases to operate as a pharmacy, shall within 10 days of the cessation of
operation, forward to the board a written notice of the closing which includes
the following information:
(1)-(2) (No change.)
(3) a statement attesting that an inventory as specified in sec.291. 17 of
this title (relating to Inventory Requirements) [of all controlled
substances on hand] has been conducted; and
(4) (No change.)
sec.291.7. Change of Pharmacist Employment.
(a) (No change.)
(b) Change of pharmacist-in-charge of a pharmacy.
(1) On the date of change of the pharmacist-in-charge of a Class A (Community)
or Class C (Institutional) Pharmacy, an inventory of the following [controlled
substances] shall be taken:
(A) (No change.)
(B) all dosage forms containing pentazocine (e.g., Talwin);
(C) all dosage forms containing phentermine (e.g., Ionamin, Fastin,
Adipex-P, etc.);
(D) all dosage forms containing diazepam (e.g., Valium);
(E) all dosage forms containing phendimetrazine ( e.g., Bontril,
Plegine, Prelu-2, etc.);
(F) all [oral liquid] dosage forms containing codeine;
(G) all dosage forms containing hydrocodone (e.g., Tussionex,
Tussend, Vicodin, Hycomine, etc.);
(H) all dosage forms containing alprazolam (e.g., Xanax); [and]
(I) all dosage forms containing triazolam (e.g., Halcion)[.] ;
(J) all dosage forms containing butorphanol (e.g., Stadol);
(K) all dosage forms containing nalbuphine (e.g., Nubain); and
(L) all dosage forms containing carisoprodol (e.g., Soma).
(2)-(4) (No change.)
sec.291.12. Fire or Other Disaster. If a pharmacy experiences a fire or other
disaster, the following requirements are applicable.
(1) Responsibilities of the pharmacist-in-charge.
(A) (No change.)
(B) The pharmacist-in-charge or designated agent shall comply with [one of]
the following procedures.
(i) If controlled substances , dangerous drugs, or DEA order forms are
lost or destroyed in the disaster, the pharmacy shall:
(I) notify the Drug Enforcement Administration (DEA), Department of Public
Safety (DPS) and Texas State Board of Pharmacy (Board) of the loss of the
controlled substances or order forms. A pharmacy shall be in compliance with
this section by submitting to each of these agencies [the board] a copy
of the Drug Enforcement Administration's report of theft or loss of controlled
substances, DEA Form-106, immediately on discovery [within 1O days] of
the loss; and
(II) notify the Texas State Board of Pharmacy in writing of the loss of
the dangerous drugs by submitting a list of the dangerous drugs lost.
(ii) If the extent of the loss of controlled substances or dangerous
drugs is not able to be determined, the pharmacy shall:
(I) take a new, complete inventory of all remaining drugs specified in
sec.291.17(c) of this title (relating to Inventory Requirements);
[controlled substances; and]
(II) submit to DEA[,] and DPS [and the board] a statement attesting
that the loss of controlled substances is indeterminable and that a new,
complete inventory of all remaining controlled substances was conducted and
state the date of such inventory[.] and
(III) submit to the board a statement attesting that the loss controlled
substances and dangerous drugs is indeterminable and that a new, complete
inventory of the drugs specified in sec.291.17(c) of this title was conducted
and state the date of such inventory.
(C) (No change.)
(D) If the pharmacy moves to a temporary location, the pharmacist shall
comply with s291.2 of this title (relating to Change of Location and/or
name). If the pharmacy returns to the original location, the pharmacist-in-
charge shall again comply with sec.291.2 of this title. [send written
notification to the board of the change of address within 10 days and further,
shall send written notification to the board of the return to the permanent
location within 10 days of the return].
(E)-(F) (No change.)
(2) (No change.)
sec.291.15. Notification of Theft or loss of a Controlled Substance or a
Dangerous Drug.
(a) Controlled Substances. For the purposes of the Act, sec.32,
subsection (a) the theft or significant loss of any controlled substance by a
pharmacy shall be reported in writing to the board immediately on
[within 10 days of] discovery of such theft or loss. A pharmacy shall be in
compliance with this subsection by submitting to the board a copy of the drug
enforcement administration report of theft or loss of controlled substances, DEA
Form 106, or by submitting a list of all controlled substances stolen or lost.
(b) Dangerous Drugs. A pharmacy shall report in writing to the board
immediately on discovery, the theft or significant loss of any dangerous drug by
submitting a list of the name and quantity of all dangerous drugs stolen or
lost.
sec.291.16. Definitions. Any term not defined in this chapter shall have the
definition set out in the Texas Pharmacy Act, sec.5 (Texas Civil Statutes,
Article 4542a-1) [House Bill 1628, sec.5, Acts of the 67th Legislature,
1981].
sec.291.17. [Controlled Substances] Inventory Requirements.
(a) General Requirements.
(1)-(4) (No change.)
(5) The inventory shall include all stocks of the following drugs
[controlled substances] on hand on the date of the inventory (including any
[controlled substances] which are out-of-date): [.]
(A) all controlled substances;
(B) all dosage forms containing butorphanol (e.g., Stadol);
(C) all dosage forms containing nalbuphine (e.g., Nubain); and
(D) all dosage forms containing carisoprodol (e.g., Soma).
(6) (No change.)
(7) The inventory record shall indicate whether the inventory is taken as of
the opening of business or as of the close of business on the inventory
date. If the pharmacy is open 24 hours a day, the opening of business shall
be 12:01 a.m. and the close of business shall be 12 midnight. The inventory
shall indicate that it is a record of drugs on-hand as of the opening or closing
of the business day. [,with the following exceptions.
[(A) In a Class A (Community) Pharmacy that is open 24 hours a day, the
inventory record shall indicate the prescription number of the last prescription
filled during the inventory.
[(B) In a Class C (Institutional) Pharmacy that is open 24 hours a day, the
inventory record shall indicate the time the inventory was completed.]
(8) The person(s) taking the inventory and the pharmacist-in-charge shall
indicate the time the inventory was taken (as specified in paragraph (7) of this
subsection) and shall sign and date the inventory with the date the inventory
was taken. The signature of the pharmacist-in-charge and the date of the
inventory shall be notarized within 72 hours or three working days of the
completed initial, annual, change of ownership and closing
[controlled substances] inventory.
(9) (No change.)
(10) The person(s) taking the inventory shall make an estimated count or
measure of all substances listed in Schedule III, IV, or V and dangerous
drugs , unless the container holds more than 1,000 tablets or capsules in
which case, an exact count of the contents must be made.
(11) The inventory of Schedule I and II controlled substances shall be listed
separately from the inventory of Schedule III, IV, and V controlled substances
which shall be listed separately from the inventory of dangerous drugs.
(12) If the pharmacy maintains a perpetual inventory of any of the drugs
required to be inventoried [controlled substances], the perpetual inventory
shall be reconciled on the date of the inventory.
(b) Initial Inventory.
(1) A new Class A (Community) pharmacy or Class C (Institutional) pharmacy
[that is registered under the Texas and Federal Controlled Substances Acts]
shall take an inventory [of all controlled substances on hand] on the opening
day of business. Such inventory shall include all stocks (including any out-
of-date drugs) of the following:
(A) all controlled substances;
(B) all dosage forms containing butorphanol (e.g., Stadol);
(C) all dosage forms containing nalbuphine (e.g., Nubain); and
(D) all dosage forms containing carisoprodol (e.g., Soma).
(2) In the event the Class A or C pharmacy commences business with none of
the drugs specified in paragraph (1) of this subsection [no controlled
substances] on hand, the pharmacy shall record this fact as the initial
inventory.
(3) The initial inventory shall serve as the pharmacy's inventory until the
next May 1, or until the pharmacy's regular general physical inventory
date, at which time the Class A or C Pharmacy shall take an annual
inventory as specified in subsection (c) of this section. [of all
controlled substances on hand; the] Such inventory may be taken within
four days of the specified inventory [this] date and shall include
all stocks (including out-of-date drugs).
(c) Annual Inventory.
(1) A Class A or C pharmacy shall take an inventory [of all controlled
substances on hand (including any which are out-of-date)] on May 1 of each year,
or on the pharmacy's regular general physical inventory date.[;]
Such inventory may be taken within four days of the specified
inventory [this] date and shall include all stocks (including out-of-
date drugs) of the following:
(A) all controlled substances;
(B) all dosage forms containing butorphanol (e.g., Stadol);
(C) all dosage forms containing nalbuphine (e.g., Nubain); and
(D) all dosage forms containing carisoprodol (e.g., Soma).
(2) A Class A or C pharmacy applying for renewal of a pharmacy license shall
include as a part of the pharmacy license renewal application a statement
attesting that an annual [controlled substances] inventory has been conducted,
the date of the inventory, and the name of the person taking the inventory.
(d) Change of Ownership.
(1) A Class A or C pharmacy that changes ownership shall take an inventory of
all of the following drugs [controlled substances] on hand (including
any [controlled substances] which are out-of-date) on the date of change of
ownership : [.]
(A) all controlled substances;
(B) all dosage forms containing butorphanol (e.g., Stadol);
(C) all dosage forms containing nalbuphine (e.g., Nubain); and
(D) all dosage forms containing carisoprodol (e.g., Soma).
(2)-(3) (No change.)
(e) Closed Pharmacies. The pharmacist-in-charge of a Class A or C pharmacy
that ceases to operate as a pharmacy shall forward to the board, within 10 days
of the cessation of operation, a statement attesting that an inventory of the
drugs specified in subsection (c) of this section [controlled
substances] on hand has been conducted, the date of closing, and a statement
attesting the manner by which the dangerous drugs and controlled
substances possessed by such pharmacy were transferred or disposed.
(f) Requirements for Class C (Institutional) Pharmacies.
(1) (No change.)
(2) Annual Inventory.
(A) An inventory shall be conducted [of all controlled substances on hand] on
May 1 of each year, or on the pharmacy's regular general physical inventory
date.[;] Such [the] inventory may be taken within four days of
the specified inventory [this] date and shall include all stocks
(including out-of-date drugs) of the following:
(i) all controlled substances:
(ii) all dosage forms containing butorphanol (e.g., Stadol);
(iii) all dosage forms containing nalbuphine (e.g., Nubain); and
(iv) all dosage forms containing carisoprodol (e.g., Soma).
(B) The annual inventory of the institution shall include all of the drugs
specified in subparagraph (A) of this paragraph [controlled substances] on
hand in the pharmacy.
(C) The inventory of the institution shall be maintained in the pharmacy; if
an inventory [of controlled substances] is conducted in other departments within
the institution, the inventory of the pharmacy shall be listed separately, as
follows:
(i) the inventory of drugs [controlled substances] on hand in the
pharmacy shall be listed separately from the inventory of drugs [the
controlled substances] on hand in the other areas of the institution; and
(ii) the inventory of drugs [controlled substances] on hand in all
other departments shall be identified by department.
(g) Change of pharmacist-in-charge of a pharmacy.
(1) On the date of change of the pharmacist-in-charge of a Class A (Community)
or Class C (Institutional) pharmacy, an inventory of the following drugs
[controlled substances] shall be taken:
(A) (No change.)
(B) all dosage forms containing pentazocine (e. g., Talwin);
(C) all dosage forms containing phentermine (e. g., Ionamin, Fastin,
Adipex-P, etc.);
(D) all dosage forms containing diazepam (e g., Valium);
(E) all dosage forms containing phendimetrazine ( e.g., Bontril,
Plegine, Prelu-2, etc.);
(F) all [oral liquid] dosage forms containing codeine;
(G) all dosage forms containing hydrocodone (e.g., Tussionex,
Tussend, Vicodin, Hycomine, etc.);
(H) all dosage forms containing alprazolam (e.g., Xanax); [and]
(I) all dosage forms containing triazolam (e. g., Halcion)[.] ;
(J) all dosage forms containing butorphanol (e.g., Stadol);
(K) all dosage forms containing nalbuphine (e.g., Nubain); and
(L) all dosage forms containing carisoprodol (e.g., Soma).
(2)-(4) (No change.)
This agency hereby certifies that the proposal has been reviewed by legal
counsel and found to be within the agency's authority to adopt.
Issued in Austin, Texas, on March 3, 1993.
TRD-9319719
Fred S. Brinkley, Jr., R.Ph., M.B.A.
Executive Director/Secretary
Texas State Board of Pharmacy
Earliest possible date of adoption: April 12, 1993
For further information, please call: (512) 832-0661
All Classes of Pharmacy
22 TAC sec.291.11
(Editor's note: The text of the following section proposed for repeal will not
be published. The section may be examined in the offices of the Texas State
Board of Pharmacy or in the Texas Register office, Room 245, James Earl Rudder
Building, 1019 Brazos Street, Austin.)
The Texas State Board of Pharmacy proposes the repeal of sec.291.11
concerning Regulation.
The repeal of this section if adopted will eliminate a section of the rules
which is no longer necessary because of adoption of other rules.
Fred S. Brinkley, Jr., R.Ph., M.B.A., executive director/secretary has
determined that for the first five-year period the repeal is in effect there
will be no fiscal implications as a result of enforcing or administering the
repeal.
Mr. Brinkley also has determined that for each year of the first five years the
repeal is in effect the public benefit anticipated as a result of enforcing the
repeal as proposed will be the protection of the health of the citizens of the
State of Texas through establishment of standards for pharmacy operations. There
will be no effect on small businesses. There is no anticipated economic cost to
persons who are required to comply with the repeal as proposed.
Comments may be submitted to Fred S. Brinkley, Jr., R.Ph., M.B.A., Texas State
Board of Pharmacy, 8505 Cross Park Drive, Suite 110 Austin, Texas 78754-4533.
The repeal is proposed under the Texas Pharmacy Act (Texas Civil Statutes,
Article 4542a-1) sec.16(a), which provides the Texas State Board of Pharmacy the
authority to adopt rules for the proper administration and enforcement of the
Act.
sec.291.11. Regulation.
This agency hereby certifies that the proposal has been reviewed by legal
counsel and found to be within the agency's authority to adopt.
Issued in Austin, Texas, on March 2, 1993.
TRD-9319722
Fred S. Brinkley, Jr., R.Ph., M.B.A
Executive Director/Secretary
Texas State Board of Pharmacy
Earliest possible date of adoption: April 12, 1993
For further information, please call: (512) 832-0661
Community Pharmacy (Class A)
22 TAC sec.sec.291.32, 291.34, 291.36
The Texas State Board of Pharmacy proposes amendments to ssec.291.32, 291.34,
and 291.36, concerning Personnel, Records, and Class A Pharmacies Compounding
Sterile Pharmaceuticals.
These amendments if adopted will correct references to rule citations in the
Class A Pharmacy rules in conjunction with amendments to the rules relating to
inventory requirements.
Fred S. Brinkley, Jr., R.Ph., M.B.A., executive director/secretary, has
determined that for the first five-year period the sections are in effect there
will be no fiscal implications as a result of enforcing or administering the
sections.
Mr. Brinkley also has determined that for each year of the first five years the
sections are in effect the public benefit anticipated as a result of enforcing
the sections as proposed will be the protection of the health of the citizens of
the State of Texas through the adoption of rules governing the operation of
Class A Pharmacies. There will be no effect on small businesses. There is no
anticipated economic cost to persons who are required to comply with the
sections as proposed.
Comments may be submitted to Fred S. Brinkley, Jr., R.Ph., M.B.A., Texas State
Board of Pharmacy, 8505 Cross Park Drive, Suite 110 Austin, Texas 78754-4533.
The amendments are proposed under the Texas Pharmacy Act (Texas Civil Statutes,
Article 4542a-1) sec.16(a), which provides the Texas State Board of Pharmacy the
authority to adopt rules for the proper administration and enforcement of the
Act; and sec.17(b), which provided the Board with the authority to specify the
minimum standards for maintenance of prescription drug records in a pharmacy.
sec.291.32. Personnel.
(a) Pharmacist-in-charge.
(1) General.
(A) (No change.)
(B) The pharmacist-in-charge shall comply with the provisions of sec.291.17 of
this title (relating to [Controlled Substances] Inventory Requirements).
(b)-(d) (No change.)
sec.291.34. Records.
(a)-(f) (No change.)
(g) Other Records. Other records to be maintained by the pharmacy:
(1)-(5) (No change.)
(6) a hard-copy of [controlled substance] inventories required by sec.291.17
of this title (relating to [Controlled Substances] Inventory Requirements);
(7)-(10) (No change.)
(h)-(j) (No change.)
sec.291.36. Class A Pharmacies Compounding Sterile Pharmaceuticals.
(a)-(b) (No change.)
(c) Personnel.
(1) Pharmacist-in-charge.
(A) General.
(i) (No change.)
(ii) The pharmacist-in-charge shall comply with the provisions of sec.291.17
of this title (relating to [Controlled Substances] Inventory Requirements).
(B) (No change.)
(2)-(4) (No change.)
(d) (No change.)
(e) Records.
(1)-(8) (No change.)
(9) Other Records. Other records to be maintained by the pharmacy:
(A)-(E) (No change.)
(F) a hard-copy of [controlled substance] inventories required by sec.291.17
of this title (relating to [Controlled Substances] Inventory Requirements);
(G)-(I) (No change.)
(10)-(11) (No change.)
(f) (No change.)
This agency hereby certifies that the proposal has been reviewed by legal
counsel and found to be within the agency's authority to adopt.
Issued in Austin, Texas, on March 2, 1993.
TRD-9319723
Fred S. Brinkley, Jr., R.Ph., M.B.A
Executive Director/Secretary
Texas State Board of Pharmacy
Earliest possible date of adoption: April 12, 1993
For further information, please call: (512) 832-0661
Chapter 303. Destruction of Dangerous Drugs and Controlled
Substances
22 TAC sec.303.1, sec.303.2
The Texas State Board of Pharmacy proposes amendments to s303.1 and
sec.303.2, concerning Destruction of Dispensed Drugs and Disposal of Stock
Prescription Drugs.
These amendments if adopted will outline procedures for the destruction of
butorphanol (Stadol), nalbuphine (Nubain) and carisoprodol (Soma) and require a
pharmacy to maintain a record of destruction of these drugs.
Fred S. Brinkley, Jr., R.Ph., M.B.A., executive director/secretary has
determined that for the first five-year period the sections are in effect there
will be no fiscal implications as a result of enforcing or administering the
sections.
Mr. Brinkley also has determined that for each year of the first five years the
sections are in effect the public benefit anticipated as a result of enforcing
the sections as proposed will be the protection of the health of the citizens of
the state of Texas through better control of the destruction of these drugs.
There will be no effect on small businesses. There is no anticipated economic
cost to persons who are required to comply with the section as proposed.
Comments on the proposal may be submitted to Fred S. Brinkley, Jr., R.Ph.,
M.B.A., Texas State Board of Pharmacy, 8505 Cross Park Drive, Suite 110, Austin,
Texas 78754-4533.
The amendments are proposed under the Texas Pharmacy Act (Texas Civil Statutes,
Article 4542a-1) sec.16(a), which provides the Texas State Board of Pharmacy the
authority to adopt rules for the proper administration and enforcement of the
Act; and sec.17(b), which provided the Board with the authority to specify the
minimum standards for maintenance of prescription drug records in a pharmacy.
sec.303.1. Destruction of Dispensed Drugs.
(a) (No change.)
(b) Drugs Returned to a Pharmacy. A pharmacist, licensed by the board, is
authorized to destroy dangerous drugs and controlled substances which have been
previously dispensed to a patient and returned to a pharmacy by the patient or
an agent of the patient. The following procedures shall be followed in
destroying these drugs.
(1) Dangerous Drugs other than tripelennamine (e.g., PBZ),
butorphanol ( e.g., Stadol), [and] nalbuphine (e.g., Nubain)
, and carisoprodol (e.g., Soma).
(A)-(B) (No change.)
(2) Controlled Substances and tripelennamine (e.g., PBZ), butorphanol
( e.g., Stadol), [and] nalbuphine (e.g., Nubain) , and
carisoprodol (e.g., Soma).
sec.303.2. Disposal of Stock Prescription Drugs.
(a) (No change.)
(b) Disposal of stock dangerous drugs. A pharmacist, licensed by the board, is
authorized to destroy stock dangerous drugs owned by a licensed pharmacy if such
dangerous drugs are destroyed in a manner to render the drugs unfit for human
consumption; provided, however, the following procedures shall be followed in
destroying any brand or dosage form of tripelennamine ( e.g. , PBZ),
butorphanol (e.g., Stadol), [and] nalbuphine (e.g.,
Nubain), and carisoprodol (e.g., Soma).
(c) (No change.)
This agency hereby certifies that the proposal has been reviewed by legal
counsel and found to be within the agency's authority to adopt.
Issued in Austin, Texas, on March 3, 1993.
TRD-9319720
Fred S. Brinkley, Jr., R. Ph., M.B.A.
Executive Director/Secretary
Texas State Board of Pharmacy
Earliest possible date of adoption: April 12, 1993
For further information, please call: (512) 832-0661
TITLE 25. HEALTH SERVICES
Part II. Texas Department of Mental Health and Mental Retardation
Chapter 407. Internal Facilities Management
Financial Services
25 TAC sec.sec.407.1-407.6, 407.22-407.24
The Texas Department of Mental Health and Mental Retardation (TXMHMR) proposes
amendments to sec.sec.407.1-407.6 and ssec.407.22-407.24, concerning standard
operating procedures and accounting. The sections would be consolidated as
financial services under an undesignated head.
The proposed amendments would primarily provide more comprehensive guidelines
and uniform procedures for fiscal operations of the department. Clarifying
language would be added to sec.sec.407.1-407.6, and sec.sec.407.22-407. 24. The
proposed amendments in s407.2 would add provisions concerning the disposal of a
deceased client's trust fund when a demand is made. Section 407. 2(d) would be
expanded to include two methods of earning interest and would allow for a non-
specific period for interest to be prorated. Section 407.3 would require all
funds which are required to be deposited in the State Treasury be deposited
within three days of receipt. For clarification, the titles of sec.sec.407.22-
407.24 would be changed from Patients Trust Fund to Trust Fund Procedures;
Patient Benefit Fund to Benefit Fund Procedures; and Processing Vouchers and
Warrants after Death of Payee to Processing Warrants and Vouchers after Death of
Payee, respectively.
Leilani Rose, director, Financial Services, has determined that there will be
no additional fiscal cost to state or local government as a result of
administering the amendments as proposed. There will be no significant local
economic impact.
Ms. Rose also has determined that the public benefit is the more uniform
procedures for fiscal operations. There will be no effect on small businesses.
There is no anticipated economic cost to persons who are required to comply with
the amendments as proposed.
Comments on the proposed amendments may be submitted to Linda Logan, Director,
Policy Development, Texas Department Mental Health and Mental Retardation, P.O.
Box 12668, Austin, Texas 78711-2668, within 30 days of publication.
The amended sections are proposed under the Texas Health and Safety Code, Title
7, sec.532.015, which provides the Texas Board of Mental Health and Mental
Retardation with rulemaking powers.
sec.407.1. Purpose. This document has been established to provide written
guidelines for fiscal operations. The intention is to impart enough information
that an employee new to this system will be able to accomplish the tasks they
need to perform. Although this manual is not all encompassing, it should provide
either the answer to a question or be able to direct an individual to the proper
source. These procedures are intended to be a meaningful guide in carrying out
the fiscal responsibilities of the Texas Department of Mental Health and Mental
Retardation. The procedures for accounting, budgeting, and wage and salary have
been developed primarily to provide for uniform procedures of reporting
financial data that is accurate, compatible, and comprehensive. Uniform
procedures are necessary for effective fiscal control, increased operating
efficiency through comparative analysis, support for appropriation requests, and
accurate public information. Uniformity of business practices and of accounting,
payroll, and budgeting procedures as applied to the departmental operations must
be maintained. It is imperative that administrative personnel become familiar
with the procedures outlined and comply with them in every respect. Any
departure that seems necessary should be explained in writing to the Director,
Financial Services, Central Office. In the event questions arise which are not
addressed in this document, or cannot be resolved based on accepted business
principles and practices, the Director of Financial Services or the Chief of
Accounting Systems Management Section, should be consulted. [Standard
operating procedures have been established primarily to cite the principles to
be followed in certain areas of administrative concern. The topics in this
subcategory may expand on topics referred to in other categories and may
likewise be treated in more detail in other subcategories. Standard operating
procedures are intended to be a flexible and meaningful guide in carrying out
the responsibilities of the Texas Department of Mental Health and Mental
Retardation. Each section should be recognized as a part of the whole and should
be used in coordination with other sections, as well as with existing statutes
and the current appropriation bill. It is intended to be an active guide, to be
changed as often as necessary. Suggestions for changes or amendments are invited
and will be given most careful consideration].
sec.407.2. Trust Funds and Personal Effects.
(a) All funds received at the facility for the personal use of an
individual client who has given consent for the facility to administer the
client's personal trust funds will have their funds deposited to the client
trust fund. [All funds received for the use or benefit of specific persons
shall be considered as patient trust funds. All funds received are subject to
any restriction imposed by donor or grantor.] These funds shall be deposited in
national or state banks [in the immediate area] that are insured by the Federal
Deposit Insurance Corporation[,] or in savings and loan associations domiciled
in the State of Texas that are insured by the Federal Savings and Loan Insurance
Corporation.
(b) At least [Not less than] 75% of the balance of the total amount
held in trust at each facility shall be invested with insured Texas financial
institutions [in time deposit certificates, savings accounts, or with the
Central Office investment plan. The rate of return and the availability for
withdrawal in case of emergency shall be considered in making the selections. As
much of the remaining balance that is not required for current distribution
should also be invested. Any exception to the minimum investment of 75% for a
particular facility must be approved by the deputy commissioner for management
and support]. Any remaining balance that is not required for current
operations of the trust fund shall also be invested.
(c) Each client trust fund account is separately insured by the Federal
Deposit Insurance Corporation or the Federal Savings and Loan Insurance
Corporation provided that adequate trust fund records are maintained by the
facility. [Subject to maintenance of adequate facility records of patient
trust funds, each individual is separately insured by the Federal Deposit
Insurance Corporation and the Federal Savings and Loan Insurance Corporation.]
This makes it possible to maintain the trust fund balance in one demand deposit
account, bank investment account, and/or savings and loan account.
(d) Earnings from the investment of pooled trust funds are to be
prorated [allocated] to individual client trust fund accounts in one
of the following ways [manner]:
(1) prorated to each client on an actual interest-earned basis; or
[For each state fiscal quarter, the interest collected from the investment of
client trust funds (including constructive receipt) will be allocated to clients
on the basis of the average balance in the account of each client. The average
balance will be determined by averaging the monthly balances for the three
months of the quarter. The monthly balance should be that of the last day of the
month. The allocation process should include all clients who had a balance on
the last day of the quarter.]
(2) prorated to each client on the basis of the average monthly balance
for the period of proration. [As the interest for a quarter is collected,
it should be accumulated in a special trust fund account to be distributed to
the individual client trust fund accounts at the end of the quarter.]
[(3) Investment should be planned so that some interest will be collected each
month or quarter and so that there will be an equitable allocation of interest
to all clients and also an equitable allocation over several fiscal quarters.]
(e) When a client dies and there are funds remaining in the client's trust
fund, such funds should be disposed of as follows:
(1) where no demand is made for disbursement of funds remaining in the
deceased client's account, the facility should dispose of such funds in
accordance with the Texas Health and Safety Code, sec.551.005. The facility
shall hold such funds in the client's trust fund account for a period of three
years. If at the end of three years, no demand has been made for disbursement of
the funds, the facility shall turn such funds over to the State Treasurer. The
State Treasurer shall hold the funds for a period of five years; and if, at the
end of that five year period, no demand has been made, the funds shall escheat
to the State and shall become a part of the General Fund;
(2) where demand is made, the facility may release the deceased client's
funds in one of the following ways.
(A) The facility shall require the claimant to produce a copy of the small
estates affidavit which has been filed in and approved by the probate court and
certified by the clerk of said court in order to prove that the claimant has
been authorized to collect the assets or a portion of the assets of the deceased
client's estate.
(B) The facility shall release any remaining trust funds to such guardian.
In order to prove that the person claiming the remaining trust funds is the
guardian of the deceased client's estate, the facility shall require the
claimant to provide letters of guardianship which indicate that the claimant is
guardian of the deceased client's estate.
(C) The facility shall release any remaining trust funds to the
representative appointed by the probate court to administer the estate. The
facility shall require the representative to produce testamentary letters or
letters of administration in order to prove that the representative has been
authorized by the probate court to collect all assets of the deceased client's
estate.
(D) If the probate court has determined that there is no necessity for
administration of the deceased client's estate, the facility shall release any
remaining trust funds to the distributees of the deceased client. The facility
shall require a claimant to produce the court order refusing application for
administration in order to prove that the claimant is collecting the remaining
trust funds pursuant to the Texas Probate Code, sec.180. In the event the court
order does not set forth the manner in which the assets of the deceased client's
estate are to be distributed, the facility shall require the claimant to obtain
a court order which shows that the claimant has been determined by the probate
court to be a lawful heir of the deceased client's estate.
(E) When any questions arise concerning the proper distribution of assets
remaining in a deceased client's trust fund, the facility is advised to seek
legal counsel.
(F) In cases where the remaining funds are $100 or less and the facility
feels reasonably sure that the person claiming the funds is the lawful heir and
there would probably not be a future dispute over distribution of said funds,
the facility may use its discretion as to whether to distribute the funds with
the caveat that the release of such funds would be without any legal protection
from potential liability by wrongfully distributing assets of the estate.
(3) Exceptions. Any funds deposited in a deceased client's trust fund pursuant
to a specific trust arrangement or any funds which have been designated for a
specific purpose by the facility prior to the death of the client shall be
disposed of pursuant to the terms of that arrangement or pursuant to the purpose
designated by the facility. Examples would include where funds are specifically
set aside by a grantor for funeral expenses or where the facility has designated
specific funds prior to the death of the client to be used to pay funeral
expenses.
(4) In order to comply with the Texas Department of Human Services' rules
concerning funds of deceased clients, the facility should, within 45 days after
the death, forward a notarized affidavit outlining the disposition of the
funds [Trust funds and any personal property held by the superintendent for
a client who has died, has taken unauthorized departure, been discharged, or
furloughed, will be disposed of as directed by Texas Civil Statutes article
3l83c, sec.3].
sec.407.3. Deposit and Investment of Funds.
(a) All funds received shall be deposited with the state treasurer or in a
national or state bank which is a member of the Federal Deposit Insurance
Corporation or in a savings and loan institution which is a member of the
Federal Savings and Loan Insurance Corporation. The balance of any bank account
must never exceed the FDIC/FSLIC-insured limit unless it is secured by a bank
pledge of collateral under the provisions of Texas Civil Statutes, Article 342-
603. All funds which are required to be deposited in the State Treasury must be
deposited within three [seven] days of receipt.
(b)-(f) (No change.)
(g) A register of all investments shall be maintained in the office of the
business manager/assistant superintendent for administration . It shall
include a description of each investment, the amount and date, interest due
dates, interest paid dates, maturity date, and reinvestment information. The
business manager/assistant superintendent for administration shall use
this register to verify collection of income and principal and to plan the
investment program.
sec.407.4. Benefit Funds: Use and Control.
(a) The Texas Health and Safety Code, sec.551.004, provides that the
superintendent /director shall be the trustee of a special fund to be
designated the benefit fund. The superintendent/director ["He] may
expend the monies [moneys] in any such fund for the education or
entertainment of the clients of the facility [inmates of the
institution,] or for the actual expense of maintaining the fund at the
institution.["]
(b) The source of benefit funds are:
(1) private donations or gifts;
(2) interest earned from investment of benefit funds;
(3) proceeds, rentals, or commissions received from vending machines;
(4) proceeds, rentals, or commissions received from pay station telephones.
(c) Except for specific purpose funds, benefit funds may be used only for the
purposes of education or entertainment of clients as a body. Each expenditure
must be of general benefit to the population of the facility. This does not mean
or imply that every client must benefit from each expenditure from the benefit
fund. The guiding principle in the expenditure of these funds is that no
partiality or preferential treatment is shown individuals or selected groups of
clients. Expenditures from benefit funds must be properly documented to show the
exact purpose and, if practical, to show the name of the clients benefiting from
the expenditure.
(d) The following are examples of expenditures that meet the requirement
pertaining to education or entertainment:
(1) purchase of supplies for a client merit/demerit system;
(2)-(6) (No change.)
(7) playground equipment, T.V. sets, record players, and stereos, for
use by the clients as a whole in the living areas [on the wards or
dormitories];
(8) (No change.)
(e)-(f) (No change. )
(g) The chaplain fund is a special purpose fund which may be provided for
recording contributions at religious services and special gifts designated for
such fund by the donor. The following lists indicate the approved source for
purchase of chaplaincy equipment and supplies. While most of the items listed in
paragraphs (2) and (3) of this subsection would be considered in the categories
of "education or entertainment" under the procedure for handling benefit funds,
the proper handling of a chaplain's fund must be based on the understanding by
the donors that the funds will be used for the purposes which are listed.
Expenditures from the fund should be limited to the items on the list which have
been approved by the chaplains, the advisory committee, or the chaplain
coordinator.
(1) [Necessary] Items [items] to be provided by the facility:
(A)-(L) (No change.)
(M) public address [PA] system;
(N) (No change.)
(O) counseling room for living areas [on each ward];
(P) (No change.)
(2) Items to be provided by facility if current appropriations are
available [Very helpful items to be provided by facility funds, if
available,] or through donations to Protestant or Catholic chaplain's fund.
Items in paragraph (1) of this subsection are also included here if current
appropriations are not available:
(A)-(B) (No change.)
(C) religious books for medical and client [patient] libraries;
(D)-(I) (No change.)
(J) pianos for living areas [dayrooms and dorms];
(K)-(M) (No change.)
(N) small hymnals for living areas [ward and dorm services];
(O)-(P) (No change.)
(Q) communication system for religious broadcasts to clients
[patients];
(R)-(T) (No change.)
(3) Important items for chaplaincy ministry cannot be the responsibility of
the facility and must come from the Protestant or Catholic chaplain's
fund or other types of gifts (most of the following items become the property of
clients):
(A) Bibles and New Testaments (Roman Catholic and Protestant -[)
(]Spanish and English);
(B)-(U) (No change.)
(h) In accordance with approved procedures, all receipts should be deposited
in a bank account and all expenditures should be made by check signed by the
business manager/assistant superintendent for administration or
administrator and countersigned by the superintendent [or ]/director
or designees. Approved purchasing procedures applicable to other funds
should be adhered to in every respect.
(i) The actual expense of maintaining benefit funds may include expenditures
to cover administrative errors which arise in the administration or disbursement
of benefit funds and trust funds, provided the following restrictions are met:
(1)-(6) (No change.)
(7) employees responsible for administrative errors in the administration or
disbursement of benefit funds and trust funds may be subject to disciplinary
action as described in the department's Personnel Operation Instruction,
406-3